Submit Deal

LANTHEUS

Summary

Lantheus is a company in the development, manufacture and commercialization of innovative diagnostic imaging agents and products.

Deals Overview

Total Deals6

Valued Deals4

Total Value£ 977 M

Avg. Deal Size£ 244 M

Market Context

Senior Management

Brian Markison
CEO
Etienne Montagut
Chief Business Officer
Meara Murphy

Sort

02 Oct 2019|United States|Medical Services

Target: PROGENICS PHARMACEUTICALS

Bidder: LANTHEUS

10 Service Providers

6 Target | 4 Bidder

22 Dealmakers

13 Target | 9 Bidder

£ 423 M

Value

06 Feb 2023|United States|Biotechnology

Target: CERVEAU TECHNOLOGIES

Bidder: LANTHEUS

5 Service Providers

2 Target | 3 Bidder

7 Dealmakers

1 Target | 6 Bidder

n/a

Value

09 Jan 2024|United States|Medical Equipment

Target: PERSPECTIVE THERAPEUTICS

Bidder: LANTHEUS

2 Service Providers

1 Target | 1 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 25 M

Value

09 Jan 2024|United States|Medical Equipment

Target: LANTHEUS (SOMERSET FACILITY)

Bidder: PERSPECTIVE THERAPEUTICS

4 Service Providers

2 Bidder | 2 Vendor

12 Dealmakers

4 Bidder | 8 Vendor

n/a

Value

13 Jan 2025|Germany|Pharmaceuticals

Target: LIFE MOLECULAR IMAGING

Bidder: LANTHEUS

11 Service Providers

4 Target | 7 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 327 M

Value

28 Jan 2025|United Kingdom|Pharmaceuticals

Target: EVERGREEN THERAGNOSTICS

Bidder: LANTHEUS

10 Service Providers

5 Target | 5 Bidder

54 Dealmakers

12 Target | 42 Bidder

£ 200 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy